• Fagron’s share buy-back program: Weekly update

    Source: Nasdaq GlobeNewswire / 06 Sep 2024 11:24:46   America/Chicago

    Regulated information
    Nazareth (Belgium)/Rotterdam (The Netherlands), 6 September 2024 – 6PM CET

    Fagron’s share buy-back program: Weekly update

    In the period from 2 September 2024 through 6 September 2024, Fagron purchased 33,500 of its owns shares at an average price of € 19.17 per share corresponding to a total amount of
    € 642,302.02.

    These purchases are part of the share buy-back program of up to 150,000 Fagron shares to fulfill Fagron’s obligations under its long-term incentive scheme, which was announced on 1 August 2024.

    The total number of own shares purchased to date is 105,000.

    More information, including a detailed overview of the purchase transactions under this program, is available on our share buy-back webpage.

    Financial calendar 2024
    10 October 2024        Trading update third quarter 2024
            
    Results and trading updates are published at 7.00 AM CET.

    Further information
    Karin de Jong
    Chief Financial Officer
    investors@fagron.com

    About Fagron
    Fagron is a leading global company active in pharmaceutical compounding, focusing on delivering personalized medicine to hospitals, pharmacies, clinics and patients in more than 30 countries around the world.

    Belgian company Fagron NV has its registered office in Nazareth and is listed on Euronext Brussels and Euronext Amsterdam under the ticker symbol ‘FAGR’. Fagron’s operational activities are managed by the Dutch company Fagron BV, which is headquartered in Rotterdam.

    In the event of differences between the English translation and the Dutch original of this press release, the latter prevails.

            

    Attachment


Share on,